Characterization of the Sphingolipidome of the Peri-Infarct Tissue during Hemorrhagic Transformation in a Mouse Model of Cerebral Ischemia
Background: Cardiovascular diseases like stroke cause changes to sphingolipid mediators like sphingosine 1-phosphate (S1P) or its ceramide analogs, which bear the potential to either alleviate or exacerbate the neurological damage. Therefore, the precise identification of alterations within the sphi...
Main Authors: | Alexandra Lucaciu, Sandra Trautmann, Dominique Thomas, Karsten Lachner, Robert Brunkhorst, Julien Subburayalu |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-09-01
|
Series: | Journal of Integrative Neuroscience |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/JIN/21/6/10.31083/j.jin2106161 |
Similar Items
-
Blood sphingolipidomics in healthy humans: impact of sample collection methodology
by: Samar M. Hammad, et al.
Published: (2010-10-01) -
The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
by: Kana Masuda-Kuroki, et al.
Published: (2023-09-01) -
The Anti-Infectious Role of Sphingosine in Microbial Diseases
by: Yuqing Wu, et al.
Published: (2021-05-01) -
The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives
by: Alexandra Lucaciu, et al.
Published: (2020-06-01) -
Sphingolipid metabolism in the development and progression of cancer: one cancer's help is another's hindrance
by: Antonia Piazzesi, et al.
Published: (2021-12-01)